Aclarion, Inc. (ACON) Showcases AI-Powered NOCISCAN for Chronic Back Pain Diagnosis at Selby Spine Conference
We recently compiled a list of the 12 AI News and Ratings You Should Not Miss. In this article, we are going to take a look ...
Aclarion Inc trading halted, volatility trading pause
Inc trading halted, volatility trading pauseMaximize Your Portfolio with Data Driven Insights:Leverage the power of ...
1ACON : What's Going On With Aclarion Stock Tuesday?
Aclarion stock is trading higher on Tuesday after the company announced it secured funding for its CLARITY trial of its ...
Aclarion Jumps 10% After Securing Full Funding For CLARITY Trial
Aclarion, Inc. (ACON) is up by 10 percent on Tuesday after announcing that it has secured full funding for its pivotal CLARITY trial.
Insider Monkey6d
Aclarion, Inc. (ACON) Showcases AI-Powered NOCISCAN for Chronic Back Pain Diagnosis at Selby Spine Conference
In this article, we are going to take a look at where Aclarion, Inc. (NASDAQ:ACON) stands against the other AI stocks investors shouldn’t miss. As artificial intelligence continues to evolve ...
The Globe and Mail3d
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site
CLARITY is a randomized study designed to demonstrate Nociscan’s ability to improve surgical outcomes while reducing costs for chronic low back pain Nociscan aims to become the gold standard in ...
Yahoo Finance5d
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site
BROOMFIELD, Colo., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary ...